Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean A Follmann

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 4, 2008
The effect of continuous versus pericycle antiretroviral therapy on IL-2 responsivenessLetha M Healey, Barbara K Hahn, Catherine A Rehm, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 23, 2011
Genotypic resistance at viral rebound among patients who received lopinavir/ritonavir-based or efavirenz-based first antiretroviral therapy in South AfricaJ Nomthandazo Dlamini, Zonghui Hu, Johanna Ledwaba, et al.
Nature Medicine|April 18, 2018
A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infectionRajeev Gautam, Yoshiaki Nishimura, Natalie Gaughan, et al.
Blood|January 17, 2004
Induction and maintenance therapy with intermittent interleukin-2 in HIV-1 infectionClaire E Farel, Doreen G Chaitt, Barbara K Hahn, et al.
AIDS (London, England)|December 16, 2010
Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individualsJason Ho, Susan Moir, Wei Wang, et al.
The Journal of Infectious Diseases|March 8, 2014
A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody responseKawsar R Talaat, Catherine J Luke, Surender Khurana, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 19, 2010
Interferon-alpha produces significant decreases in HIV loadJorge A Tavel, Chiung-Yu Huang, Jean Shen, et al.
Nature Immunology|March 20, 2026
Improved VSV-Ebola-GP booster vaccination approach promotes antibody affinity maturation and durable anti-Ebola immunity in humansSurender Khurana, Olivia Posadas, Lela Kardava, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 31, 2016
Impact of Intravenous Immunoglobulin on Survival in Necrotizing Fasciitis With Vasopressor-Dependent Shock: A Propensity Score-Matched Analysis From 130 US HospitalsSameer S Kadri, Bruce J Swihart, Stephanie L Bonne, et al.
The Journal of Infectious Diseases|December 24, 2024
Vector induced humoral responses after rVSVΔG-ZEBOV-GP immunization identify vaccinated individuals and correlate with Ebola virus glycoprotein antibodiesPrabha Chandrasekaran, Irina Maljkovic Berry, Viviane Callier, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 4, 2008
The effect of continuous versus pericycle antiretroviral therapy on IL-2 responsivenessLetha M Healey, Barbara K Hahn, Catherine A Rehm, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 23, 2011
Genotypic resistance at viral rebound among patients who received lopinavir/ritonavir-based or efavirenz-based first antiretroviral therapy in South AfricaJ Nomthandazo Dlamini, Zonghui Hu, Johanna Ledwaba, et al.
Nature Medicine|April 18, 2018
A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infectionRajeev Gautam, Yoshiaki Nishimura, Natalie Gaughan, et al.
Blood|January 17, 2004
Induction and maintenance therapy with intermittent interleukin-2 in HIV-1 infectionClaire E Farel, Doreen G Chaitt, Barbara K Hahn, et al.
AIDS (London, England)|December 16, 2010
Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individualsJason Ho, Susan Moir, Wei Wang, et al.
The Journal of Infectious Diseases|March 8, 2014
A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody responseKawsar R Talaat, Catherine J Luke, Surender Khurana, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 19, 2010
Interferon-alpha produces significant decreases in HIV loadJorge A Tavel, Chiung-Yu Huang, Jean Shen, et al.
Nature Immunology|March 20, 2026
Improved VSV-Ebola-GP booster vaccination approach promotes antibody affinity maturation and durable anti-Ebola immunity in humansSurender Khurana, Olivia Posadas, Lela Kardava, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 31, 2016
Impact of Intravenous Immunoglobulin on Survival in Necrotizing Fasciitis With Vasopressor-Dependent Shock: A Propensity Score-Matched Analysis From 130 US HospitalsSameer S Kadri, Bruce J Swihart, Stephanie L Bonne, et al.
The Journal of Infectious Diseases|December 24, 2024
Vector induced humoral responses after rVSVΔG-ZEBOV-GP immunization identify vaccinated individuals and correlate with Ebola virus glycoprotein antibodiesPrabha Chandrasekaran, Irina Maljkovic Berry, Viviane Callier, et al.
Pageof 6